A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.

Neuropharmacology
Angel Arevalo-MartinCarmen Guaza

Abstract

Infection of mice with Theiler's murine encephalomyelitis virus (TMEV) leads to the development of TMEV-induced demyelinating disease (TMEV-IDD), an autoimmune, demyelinating and neurodegenerative pathology that serves as a model of multiple sclerosis. Activation of endogenous CB₁/CB₂ cannabinoid receptors inhibits inflammation and improves the clinical status of TMEV-IDD animals. In the present study, mice with established TMEV-IDD were treated with the CB₁/CB₂ receptor agonist WIN 55,212-2 (WIN), which restored self-tolerance to a myelin self-antigen while ameliorating the disease in a long-term manner. Accordingly, disruption of self-tolerance with cyclophosphamide provoked chronic relapse. Furthermore, transfer of splenocytes from WIN-treated TMEV-IDD mice to TMEV-infected mice at disease onset prevented the autoimmune inflammatory response and motor impairment. The therapeutic effect of WIN correlated with a decrease in the activation of CD4⁺CD25⁺Foxp3⁻ T cells and an increase in regulatory CD4⁺CD25⁺Foxp3⁺ T cells in the CNS, along with alterations in the cytokine and chemokine milieu. These findings demonstrate for the first time that the suppression of autoimmune responses to myelin antigens underlies the therapeutic eff...Continue Reading

References

Apr 2, 1976·Science·H L Lipton, M C Dal Canto
Nov 1, 1994·Immunopharmacology·I WirguinT Brenner
Jan 1, 1994·Annals of Neurology·R T Johnson
Aug 26, 1998·Immunology Today·T W KleinH Friedman
Jan 18, 2003·Science·Chandrashekhar Pasare, Ruslan Medzhitov
Apr 17, 2003·The Journal of Clinical Investigation·J Ludovic Croxford, Stephen D Miller
Nov 5, 2003·Nature Reviews. Neuroscience·Daniele Piomelli
Mar 8, 2005·Journal of Neurochemistry·Leyre MestreCarmen Guaza
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Santiago ZelenayJocelyne Demengeot
May 3, 2005·Nature Reviews. Immunology·Thomas W Klein
Mar 31, 2006·Proceedings of the National Academy of Sciences of the United States of America·Anke WittingNephi Stella
Mar 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cristina BenitoJulián Romero
Apr 3, 2007·Journal of Neuroimmunology·Manuel Comabella, Roland Martin
Jul 13, 2007·Brain : a Journal of Neurology·Diego CentonzeMauro Maccarrone
Nov 27, 2007·Journal of Neuroimmunology·J Ludovic CroxfordDavid Baker
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Sep 11, 2008·Current Pharmaceutical Design·David Baker, Gareth Pryce
Jul 15, 2009·The Journal of Experimental Medicine·Elizabeth C NowakRandolph J Noelle
Jun 16, 2011·The Journal of Pharmacology and Experimental Therapeutics·Rupal PandeyPrakash S Nagarkatti

❮ Previous
Next ❯

Citations

Sep 14, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Aitor G GranjaEduardo Muñoz
Apr 23, 2013·Pharmacology, Biochemistry, and Behavior·Peter J McLaughlinJohn D Salamone
Feb 11, 2014·Brain, Behavior, and Immunity·Paula Suárez-PinillaBenedicto Crespo-Facorro
Mar 12, 2016·Progress in Lipid Research·Fabio Arturo IannottiStefania Petrosino
May 20, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rebecca H RobinsonToby K Eisenstein
Nov 30, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Thea Magrone, Emilio Jirillo
Nov 22, 2013·Biochemical Society Transactions·Daniel García-OvejeroFrancisco Molina-Holgado
Dec 14, 2019·Nature Reviews. Neurology·Luigia CristinoVincenzo Di Marzo
May 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aitzkoa Lopez de LapuenteKoen Vandenbroeck
Jan 13, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Geraldine PottierAbraham Martín
May 26, 2021·Cannabis and Cannabinoid Research·Xandy Melissa Rodríguez MesaSandra Paola Santander González

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here